The protective effects of volatile anaesthetics against ischaemia-reperfusion injury have been shown in vitro, but clinical studies have yielded variable results. We hypothesized that, in children, sevoflurane provides superior cardioprotection after cardiac surgery on cardiopulmonary bypass (CPB) compared with totally intravenous anaesthesia (TIVA).
INTRODUCTION
Most of the cases of open-heart surgery require the use of cardiopulmonary bypass (CPB) with cardioplegic arrest of the heart. In both adults and children, even with optimal myocardial protection and surgical technique, postoperative myocardial stunning and necrosis are common problems in the intensive care unit (ICU). Following the landmark study of Murry in 1986 demonstrating the protective effects of ischaemic preconditioning in animal models [1] , there has been a large interest in the application of these findings in cardiac surgery. There is strong evidence of the efficacy of conditioning by volatile anaesthetics in experimental models [2, 3] and many of the involved molecular mechanisms have been elucidated [4] [5] [6] . However, the question of its clinical relevance remains open. Multiple prospective, randomized controlled trials (RCTs) [7] [8] [9] [10] , observational studies [11] and high-quality meta-analyses [12] in adult patients have come to contradicting results. The paediatric population has been much less extensively studied. It is known that in experimental models, conditioning can be influenced by age [13] and in 2005, Malagon et al. performed an RCT comparing midazolam, propofol and sevoflurane anaesthesia in children undergoing repair of congenital heart defects under CPB [14] . They included 90 patients with mean group ages ranging from 6 to 14 months. In their analysis, they were unable to find any significant differences in their primary end-point of cardiac troponin T (cTnT) release in the first 24 h after surgery. They concluded that in contrast to previous adult data from coronary artery bypass graft (CABG) surgery, sevoflurane does not significantly reduce cTnT levels compared with propofol in paediatric cardiac surgery. In their study, patients with relatively simple as well as highly complex surgical procedures (such as arterial switch and Fontan procedures) were included, some requiring deep hypothermic circulatory arrest (DHCA). Additionally, the primary analysis did not separate cyanotic patients from acyanotic ones and surgical as well as CPB techniques were not controlled. For these reasons, the question arises as to what extent their results and conclusions might be generalized. It remains to be determined whether certain subsets of paediatric patients stand to benefit from anaesthetic conditioning with volatile agents and whether this is reflected in outcome measures other than postoperative troponin levels.
We hypothesized that compared with totally intravenous anaesthesia (TIVA), sevoflurane would lead to lower postoperative levels of cardiac troponin, better systolic and diastolic function as well as less systemic inflammation. Our primary end-point was the postoperative peak value of troponin. Secondary end-points were perioperative cardiac function [as determined by brain-type natriuretic peptide (BNP), echocardiography, and postoperative need for vasopressors and inotropes], short-term clinical outcomes [duration of intubation, ICU length of stay (LOS) and hospital LOS], postoperative inflammatory profile, and pulmonary, renal and hepatic function.
METHODS
This prospective, RCT was approved by our institutional and cantonal ethics committee (Kantonale Ethikkommission, University of Zurich, trial number Stv 37/2007) and the written informed consent was obtained from the patients' parents. Patients undergoing open-heart cardiac surgery (repair of atrial septal defect, ventricular septal defect, atrioventricular septal defect, tetralogy of Fallot, double-outlet right ventricle and mitral or aortic valve repair) under CPB with cardioplegic arrest at the University Children's Hospital Zurich were eligible. Other inclusion criteria included age 1-90 months and weight 3-30 kg. We excluded neonates, reoperations, emergency surgery, infective endocarditis and patients undergoing surgery for major anomalies (Risk Adjustment for Congenital Heart Surgery 1/RACHS-1 scores above 3 [15] ). Other exclusion criteria were preoperative need for inotropic support, perioperative steroid therapy, presence of contraindications to the use of transoesophageal echocardiography (TEE) and presence of any contraindication to the use of propofol (sensibility to propofol) or sevoflurane [history of malignant hyperthermia, postoperative nausea and vomiting (PONV)]. Patients were randomized into either a TIVA or a sevoflurane group (Fig. 1 ). Based on their age, patients in the TIVA group received either midazolam (under 6 months) or propofol (above 6 months) due to our institutional regulatory restrictions on the use of propofol in children. Randomization by closed envelopes was used for making group assignments. The team responsible for postoperative care and laboratory staff were blinded to the randomization.
Primary and secondary end-points
The primary end-point was the postoperative peak value of cardiac troponin I/T (cTnI/T) in the first 24 h following admission to the ICU, with a normal range <10 µg/l for cTnI and <0.01 µg/l for cTnT, respectively. Secondary end-points included parameters of perioperative cardiac function [ pro-B-type natriuretic peptide/ N-terminal pro-B-type natriuretic peptide ( proBNP/NT-proBNP), perioperative development of systolic and diastolic function assessed by echocardiography, postoperative vasopressor and inotrope requirements], short-term clinical outcomes (duration of mechanical ventilation, length of ICU/hospital stay) and the postoperative inflammatory profile [peak concentrations of interleukin-6 (IL-6), interleukin-8 (IL-8), transforming growth factor-β (TGF-β) and C-reactive protein (CRP) in the first postoperative 24 h]. Postoperative pulmonary, hepatic and renal function was assessed [ratio of partial pressure of oxygen to inspired oxygen fraction (PaO 2 /FiO 2 ), aspartate aminotransferase (AST), alanine aminotransferase (ALT), creatinine clearance].
Perioperative management
Anaesthetic technique. Patients were premedicated with oral or rectal midazolam (0.5 mg/kg). In the operating room, the 5-lead electrocardiogram, arterial oxygen saturation, end-tidal CO 2 , bispectral index, radial or femoral arterial pressure, central venous pressure, TEE and urine output were routinely monitored in all patients. In the sevoflurane group, anaesthesia was induced with sevoflurane by mask. Following placement of an IV line, fentanyl 10 μg/kg and pancuronium 0.1 mg/kg were administered and the trachea was intubated. Anaesthesia was maintained with fentanyl boli (20-30 μg/kg) according to clinical needs, remifentanil 0.5-4 μg/kg/min in continuous infusion and inhaled sevoflurane for an end-tidal concentration of 1-2%. During CPB, sevoflurane was administered through the oxygenator. In the TIVA group, general anaesthesia was induced intravenously with fentanyl 10 μg/kg, midazolam 0.1 mg/kg and pancuronium 0.1 mg/kg. Anaesthesia was maintained with fentanyl boli (20-30 μg/kg) according to clinical needs, and either continuous infusion of remifentanil 0.5-4 μg/kg/min and propofol 4-12 mg/kg/h (above 6 months) or sufentanil 1.5 μg/kg/h and midazolam 0.1 mg/kg/h (below 6 months). Lung-protective, pressure-controlled ventilation was used to achieve normocarbia and normoxia.
Surgery and cardiopulmonary bypass. CPB procedure, cold blood cardioplegia (Necker-Paris solution: magnesium 16 nM, kalium 16 mM, chloride 49 mM, procain 1 mM/20 ml) administered into the aortic root every 15-20 min and surgical techniques under normothermia or moderate hypothermia (34°) were standardized. Every patient was operated by one of two senior cardiac surgeons. CPB priming was a standardized mixture of crystalloids, colloids and blood (depending on the expected pump haematocrit). Ultrafiltration and post-CPB-modified ultrafiltration were routinely used. Cold blood cardioplegia was administered in the aortic root or selectively into the coronary arteries every 15-20 min. A constant perfusion pressure between 40 and 50 mmHg was maintained during CPB with boli of phenylephrine according to clinical needs. The use of inotropes coming off bypass, typically a combination of low-dose epinephrine and milrinone, was at the discretion of the anaesthesiologist.
Intensive care unit management. On the paediatric surgical ICU, lung-protective ventilation was continued, initially with pressure-support. For analgesia, patients received a continuous intravenous infusion of morphine 0.1 mg/kg/h. Boli of 0.1 mg/kg of midazolam were administered for agitation during awakening, at the discretion of the intensivist. The administration of steroids during the first 24 h led to the exclusion of the child from the study because of possible interactions with the inflammatory response; hence, their use in PONV was avoided.
Vasoactive and inotrope needs on admission to the ICU were recorded and the vasoactive-inotrope score (VIS) [16] calculated as follows: VIS = doses of dopamine + dobutamine + 100 × epinephrine + 10 × milrinone + 10 000 × vasopressin + 100 × norepine- 
Statistics
A power analysis demonstrated that a sample size of totally 80 patients would have a power of 95% to detect a difference in cardiac troponin I of 2 ng/ml as a primary end-point [8, 14] using a two-sample t-test with a 0.05 two-sided significance level. Continuous variables were analysed using two-way analysis of variance (ANOVA) and ANOVA for repeated-measures as appropriate. When necessary, variables were logarithmically transformed prior to analysis. The subgroup analysis of acyanotic patients below 6 months was performed using the independent samples t-test. Categorical variables were analysed using Fisher's exact test. A change in troponin (cTnI to cTnT) and BNP assays ( proBNP to NT-proBNP) during the study was taken into account in the analysis by inserting an additional factor for assay type into the ANOVA, permitting both the old and new assays to be analysed together. Statistical analyses of data were performed using SPSS 20 (SPSS, Inc., Chicago, IL, USA). Data are expressed as mean (standard deviation) or median [interquartile range (IQR)] as appropriate. Two-sided P-values less than 0.05 were considered statistically significant.
RESULTS
Sixty-six patients undergoing open-heart surgery under CPB at the University Children's Hospital Zurich from 2007 to 2011 were considered for this trial. Parents of 6 children did not consent to the study, 60 patients were included and randomized. One patient was excluded from the primary analysis due to intraoperative anaphylaxis requiring administration of steroids, leaving 59 patients for analysis. Three patients in the TIVA group were crossed-over to the sevoflurane group due to difficulties obtaining intravenous access; they were analysed in the sevoflurane group. Baseline demographic data and clinical characteristics were comparable in both groups ( Table 1 ). The median patient age was 5.3 months (IQR 3.6-12.9). A RACHS-1 score of 3 was the highest score included in our study, which was present in 42% of acyanotic patients, and in 44% of the cyanotic ones. In the acyanotic subgroup, the most common lesions were atrioventricular canal and ventricular septal defect. The predominant lesion in the cyanotic subgroup was tetralogy of Fallot (Table 2) . No patients underwent DHCA. Of the 28 patients randomized to TIVA, 11 received propofol and 17, due to their age, received midazolam. Preoperative hepatic and renal function was normal in both groups.
No statistically significant difference was detected in our primary end-point of peak postoperative cTnI/T concentrations {relative reduction with sevoflurane compared with TIVA of 20% [95% confidence interval (CI) reduction of 48% to increase of 21%, P = 0.28} (Table 3) . As our institution's laboratory changed troponin assays during the course of the study, both troponins I and T were considered. The cyanotic and acyanotic subgroups differed significantly in peak postoperative cTnI/T (P <0.001) (Fig. 2) . In acyanotic patients below 6 months (sevoflurane versus midazolam), sevoflurane led to a statistically significant reduction in peak postoperative troponin levels of 46% (95% CI 29-71%, P = 0.002) compared with midazolam ( Fig. 3 and Table 4 ). In cyanotic patients under 6 months, there was no significant difference in postoperative troponin level between the two groups.
In our primary and subgroups analyses, we did not detect any significant difference in any of our secondary end-points (Tables 3  and 4 ). Peak postoperative proBNP/NT-proBNP levels did not differ with sevoflurane compared with TIVA (relative increase of 13%, 95% CI reduction of 33% to increase of 88%, P = 0.64). We did not find any significant difference in postoperative inotrope requirements measured with the VIS, duration of intubation, ICU LOS or hospital LOS. Cyanotic patients had longer durations of mechanical ventilation, ICU LOS (median 4.5 vs 2 days) and hospital LOS (median 14 vs 12 days for the TIVA group) than acyanotic patients (Table 3) .
Postoperative inflammatory profiles characterized by IL-6, IL-8, TGF-β and CRP did not differ between the sevoflurane and TIVA groups nor between the acyanotic and cyanotic subgroups. There was a tendency in acyanotic children under 6 months to lower levels of IL-6 and TGF-β with sevoflurane compared with midazolam (Table 4) .
There was no significant difference in PaO 2 /FiO 2 , AST, ALT or creatinine clearance between the sevoflurane and TIVA groups (data not shown). 
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In the echocardiographic analysis, there was no significant relationship between the anaesthetic used and the temporal development of the EF, FAC, FS, s 0 lat or med, IVRT, E/E 0 lat ratio or E/E 0 med ratio. Due to the high incidence of patients with perioperative tachycardia, E/A fusion prohibited reliable evaluation of the E/A ratio in several cases (Table 5) .
Postoperative global haemodynamic parameters, haemoglobin and glucose did not differ significantly between the two anaesthetics (data not shown).
DISCUSSION
Our study shows that, in acyanotic patients under 6 months of age, sevoflurane anaesthesia leads to a statistically significant reduction of postoperative levels of cTnI/T compared with midazolam.
In cyanotic patients in this age group this effect was not present. TIVA and sevoflurane led to similar levels of postoperative troponin release in the main patient collective and all other subgroups.
These findings differ from the results previously published by Malagon et al. [14] , in which sevoflurane, midazolam and propofol were equivalent in terms of postoperative troponin release. The lack of a difference in postoperative troponin levels between the midazolam and sevoflurane groups in cyanotic patients in our study is compatible with experimental and clinical evidence. It has been shown in animal models that immature cyanotic hearts cannot be conditioned [17] . A review of Danish registry data [11] showed that sevoflurane reduced mortality only in patients without a history of previous angina, suggesting that in patients who have already undergone chronic ischaemic preconditioning, further conditioning may not be possible.
The comparable troponin levels with sevoflurane and propofol in our findings might be due to conditioning effects of propofol itself, although this remains controversial [8] . Various components of the propofol emulsion have recently been shown to possess anti-inflammatory, immunomodulatory and antioxidant properties. Based on experimental studies, propofol may further reduce ischaemia-reperfusion injury, and improve functional and metabolic recovery following reperfusion [18] .
Our median peak concentrations of troponin (5.39 µg/l for midazolam) are comparable with other studies although slightly higher than published by Malagon et al. [14] . With midazolam they reported peak cTnT concentrations of 2.7 µg/l (IQR 1.9-3.5), but with shorter bypass and aortic clamping times than in our study. This might explain the slight discrepancy. Immer et al. reported similar peak concentrations of cTnT in a paediatric population operated on CPB (4.06 µg/l [range 0.11-13.87 µg/l]) [19] . Additionally, they found varying levels depending on the extent of surgical manipulation. The perfusion technique used on CPB (including type of cardioplegia, temperature of the patient, pumpflow and haemodynamic management) could also add an important source of variation in reported postoperative cTnT levels. Unfortunately, these data are rarely reported in the literature, making direct comparison of studies difficult.
It has been shown in adults undergoing CABG that preconditioning with sevoflurane prior to CPB can reduce postoperative levels of NT-proBNP [7] . We could not find any studies examining these effects in the paediatric population. Gessler et al. showed preoperative values to be prognostically relevant in children undergoing surgery for congenital heart defects [20] . We documented higher postoperative NT-proBNP values than Gessler et al.; however, our values were measured for 12 h postoperatively, in contrast to 3-h post-CPB in their study [20] . Our patients generally reached their peak values at 12 h. The fact that in our study neither postoperative BNP levels nor inotrope requirements differed between the two groups suggests that both anaesthetic techniques probably lead to comparable extents of myocardial dysfunction. This is in agreement with our echocardiographic data, which indicate that sevoflurane anaesthesia does not lead to superior postoperative systolic or diastolic function compared with TIVA.
CPB and surgery trigger a well-known systemic inflammatory reaction, with the risk of postoperative myocardial injury and systemic damage. Following restitution of coronary flow to the ischaemic myocardium, ischaemia-reperfusion injury sets in. Lately, the concept of certain anaesthetics eliciting preconditioninglike effects has received a lot of attention; in particular, the role of volatile anaesthetics has been researched intensively. Many experimental studies [3, 7] have demonstrated beneficial effects of volatile anaesthetics on ischaemia-reperfusion injury in various organ systems, such as lungs, liver and kidneys. However clinical studies thus far performed primarily in adults undergoing CABG [8, 9, 11] and valve repair [10, 21] , have produced variable results [22] . Previous studies have shown the paediatric heart to possibly be more vulnerable to ischaemia-reperfusion injury than the adult one [23] . The balance of inflammatory and antiinflammatory cytokines plays an important role in determining the overall reaction to CPB [8, 9, 11, 24] . Postoperative myocardial dysfunction has been found to correlate with the inflammatory response [10, 21, 24] . Furthermore, ultrafiltration and modified ultrafiltration can reduce levels of inflammatory mediators directly after CPB, possibly translating to slightly improved short-term clinical outcomes [3, 7] . We did not find any statistically significant differences in the peak concentrations of IL-6, IL-8 or TGF-β. However, we noted a tendency towards lower levels in the subgroup of acyanotic patients less than 6 months of age with sevoflurane compared with midazolam. Our values were higher than in a previous study by Hövels-Gürich et al. who analysed postoperative cytokine profiles in neonates undergoing arterial switch operations with DHCA [24] , measuring maximal mean postoperative IL-6 levels of 250-500 pg/ml and IL-8 levels of 75-200 pg/ml. However, dexamethasone was administered before sternotomy, with potentially significant effects on the inflammatory reaction. Our study has several limitations. Firstly, our laboratory assays of troponin and BNP changed in the course of the study from cTnI to cTnT, and from proBNP to NT-proBNP. This was taken into account in the statistical analysis.
Secondly, the anaesthesiologists could not be blinded to the anaesthetic technique used. However, the staff members who collected postoperative data, the ICU team as well as the laboratory staff were duly blinded to the randomization.
Another limitation resulted from the relatively low number of patients. We decided to end our study prematurely due to a complete change of our surgical and perfusionist staff. Not doing so would have introduced considerable heterogeneity into our patient population, prohibiting any reasonable comparisons. Additionally, as our study was meant to reflect 'daily clinical practice', we did not impose any intraoperative or postoperative management protocols on our staff. This might have introduced some heterogeneity into our population. Lastly, our study was not designed to detect a difference in postoperative troponin levels in patients below 6 months. The statistically significant lower troponin levels with sevoflurane compared with midazolam only became apparent in a post hoc subgroup analysis. Additionally, as the assignment to midazolam or propofol in the TIVA group was based on age alone (due to the minimal age restrictions imposed on propofol's use), age may be a confounder in the TIVA arm of the study. Therefore, interpretation of these results warrants caution.
CONCLUSIONS
We did not detect any significant differences in our primary endpoint of postoperative troponin release between the sevoflurane and TIVA groups within the entire group of patients studied. However, in our post hoc subgroup analysis, we found that in acyanotic patients less than 6 months of age, sevoflurane leads to significantly lower postoperative troponin levels compared with midazolam. In these patients, we also documented a tendency towards lower levels of postoperative inflammation in the sevoflurane group. However, due to the lack of any differences in biomarkers of cardiac dysfunction or short-term clinical outcomes, the relevance of this finding remains unclear. Based on these observations, consideration should be given to using sevoflurane instead of midazolam in children under 6 months with acyanotic lesions. In children above 6 months, propofol and sevoflurane seem to be similar with regard to cardioprotection. This trial further illustrates that the complexity of protection mechanisms might be underestimated. There is a need for future studies and their role will be to identify those children most likely to benefit from anaesthetic conditioning-be it with sevoflurane or propofol.
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